NJ-SPIRENT-COMM
9.2.2021 09:02:10 CET | Business Wire | Press release
Spirent Communications plc (LSE:SPT), the leading provider of test, assurance, and analytics solutions for next-generation devices and networks, today released its second annual 5G outlook report, based on analysis and takeaways from over 600 global 5G engagements in 2020. The “5G 2021: Market Drivers, Insights & Consideration” report provides insights from across the 5G eco-system on the current status of 5G, illustrating the accelerated timetables from service providers in upgrading to 5G standalone (SA) with the new 5G Core, and revealing how 5G is driving new initiatives and sector engagements. The report is available at www.spirent.com/assets/the-spirent-2021-5g-report .
“2020 was certainly a year to remember, not just because of the unprecedented challenges presented by COVID-19, but also because of the rapid development for the telecom industry,” said Spirent Head of 5G Strategy, Steve Douglas. “Telecom is keeping its sights firmly focused on 5G’s future, not in spite of the challenges of the pandemic, but because of them, and our latest report gives an unparalleled view of the current status of 5G and the trends we’re seeing for the year ahead, based on the investments, research, testing and innovation by the leading 5G players.”
The report draws on Spirent’s work with operators, network equipment manufacturers, government, military, and device makers across the globe. It provides an updated, behind-the-scenes view of what’s gone right so far, where challenges persist, and how what was learned during the year is impacting priorities for 2021 and beyond. Key findings from the report include:
- 5G SA core timetables accelerated rapidly: 5G activity surged in 2020 with accelerated timetables from service providers to deliver 5G SA core deployments, following non-standalone’s (NSAs) inability to really wow customers and deliver a solid new revenue proposition. Service Provider engagement increased nearly 50% as Service Assurance integration ramped up, and leading operators accelerated 5G standalone network strategies and new 5G core deployments.
- Because 5G is moving so fast, operators are turning to partners to deliver key elements : Through service contracts, elements that would previously have been delivered inhouse are now being delivered by trusted partners, as operators need to be able to move quickly to keep up with the complexity of 5G and the accelerated timetables.
- 5G is driving new initiatives and engagements: The year saw notable growth in engagements with government, military and academia around 5G experimentation and security initiatives, as governments explore new use cases. Other notable initiatives include Cloud hyperscalers exploring operator edge partnerships, Open RAN being explored in support of supply chain diversity initiatives, and multichannel video programming distributors (MVPDs) accelerating their plans for 5G.
- Automated Assurance and 5G are the new dynamic duo: Whether it was a core network buildout, lab certification, or new service delivered, 5G plus Automated Assurance were the dynamic duo that customers turned to as they sought to continue pushing forward with their 5G plans, with 80% of Spirent’s assurance business focused on 5G work.
- The trend of accelerated timetables is here to stay: While the pandemic has undoubtedly accelerated 5G timetables, it seems likely this accelerated trend is here to stay.
“In many ways, the pandemic has accelerated trends that we hadn’t anticipated gaining steam for at least another couple of years,” said Douglas, “whether fixed wireless access driven by working from home, or automation required to safely conduct field testing with limited personnel. While there were delays, by and large 5G powered ahead and remained in control of its destiny.”
“Spirent provides us with a real-world glimpse into 5G deployments today,” said Patrick Kelly, Founder and Principal Analyst at Appledore Research. “Spirent has a unique perspective in the 5G ecosystem as a leader in test and assurance solutions. The report provides insights into the current status of 5G and what’s coming next, particularly in 5G core, transport, network security, Open RAN progress, and the role of automated assurance.”
Spirent’s “5G 2021: Market Drivers, Insights & Consideration ” report offers a broad view of market-wide 5G challenges, opportunities and plans, and is available as a download at https://www.spirent.com/assets/the-spirent-2021-5g-report .
About Spirent
Spirent Communications plc. (LSE: SPT) is the leading global provider of automated test and assurance solutions for networks, cybersecurity, and positioning. The company provides innovative products, services and managed solutions that address the test, assurance and automation challenges of a new generation of technologies, including 5G, SD-WAN, cloud, autonomous vehicles and beyond. From the lab to the real world, Spirent helps companies deliver on their promise to their customers of a new generation of connected devices and technologies. For more information, please visit www.spirent.com and follow us on LinkedIn , Twitter and Facebook .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210209005179/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
